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ABSTRACT
International Journal of Exercise Science 10(2): 188-196, 2017 Controlled or paced
breathing is often used as a stress reduction technique but the impact on blood pressure (BP) and
sympathetic outflow have not been consistently reported. The purpose of this study was to
determine whether a controlled breathing (12 breaths/min, CB) rate would be similar to an
individual’s spontaneous breathing (SB) rate. Secondly, would a CB rate of 12 breaths/min alter
heart rate (HR), BP, and indices of muscle sympathetic nerve activity (MSNA). Twenty-one
subjects (10 women, 11 men) performed two trials: SB, where the subject chose a comfortable
breathing rate; and CB, where the subject breathed at a pace of 12 breaths/min. Each trial was 6
min during which respiratory waveforms, HR, BP (systolic, SBP; diastolic, DBP), and MSNA
were recorded. During CB, the 6 min average breathing frequency (14±4 vs 12±1 breaths/min,
P<0.05 for SB and CB, respectively), MSNA burst frequency (18±12 vs 14±10 bursts/min, P<0.01)
and MSNA burst incidence (28±19 vs 21± 6 bursts/100 heart beats, P<0.01) were significantly
lower than during SB. HR (66±9 vs 67±9 beats/min, P<0.05) was higher during CB. SBP (120±13
vs 121±15 mmHg, P=0.741), DBP (56±8 vs 57±9 mmHg, P=0.768), and MSNA total activity (166±
94 vs 145±102 a.u./min, P=0.145) were not different between the breathing conditions. In
conclusion, an acute reduction in breathing frequency such as that observed during CB elicited a
decrease in indices of MSNA (burst frequency and incidence) with no change in BP.
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INTRODUCTION
Respiration can be controlled by voluntary and involuntary functions of the nervous system
(11). The medulla contains inspiratory and expiratory centers in the ventral respiratory group
that coordinate the breathing cycle (11). During quiet, or spontaneous breathing (SB),
inspiratory and expiratory neurons send alternating signals to the integrating centers in the
spinal cord to contract or relax the muscles involved in respiration, yielding a respiration rate
of approximately 12-15 breaths/min (10, 11). The same pathways are not utilized during
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voluntary control of respiration (such as paced or controlled breathing, CB). Conscious control
of respiration originates in the motor cortex of the frontal lobe and projects along corticospinal
tracts to the integrating centers in the spinal cord (11).
Associated with normal respiration is a fluctuation in heart rate (HR). HR increases upon
inspiration and decreases upon expiration. This occurrence likely stems from vagal
suppression, which will decrease HR, during inspiration (8) and/or a baroreflex mediated
response (3). A baroreflex response refers to how baroreceptors on the aorta and carotid
arteries detect mechanical deformation from the blood on the arterial walls and the resultant
moderation of cardiovascular components like HR to adjust to the either increased or
decreased pressure (17). While CB is not “natural” breathing, it is commonly used by singers
and people who participate in yoga or meditative breathing practices (11). Additionally,
biathletes, archers, and hunters use a CB-like technique just before shooting, in order to
improve accuracy (1). For example, biathletes strive to quickly (<1 min) lower their HR to no
more than 80% of maximal HR. In this range, the athlete can control his/her breathing in
order to time the shot with bodily movements associated with the higher breathing frequency
due to the intense exercise (19).
The natural respiration cycle has also been shown to affect blood pressure (BP) and neural
outflow of muscle sympathetic nerve activity (MSNA), with MSNA decreasing during
inspiration and increasing during expiration in a cyclical fashion (4, 13). Low frequency CB
has been shown to lower MSNA. For example, Hering et al. (2013) implemented a protocol of
<10 breaths/min in hypertensive males. They found that an acute (one 15 min session)
exposure elicited a reduction in MSNA but not BP. However, long-term use (15 min per day
for 8-weeks) showed no reduction in MSNA however a lowering of some, but not all, BP
indices (7). It is unclear as to why there is a difference between acute and long-term
interventions. This may be related to a reduction in other vasoactive agents and hormones
during the long-term treatment. CB or guided breathing is often used as a relaxation
technique and has been shown to be quite effective in reducing BP in a variety of populations,
especially the hypertensive and diabetic populations (6, 9, 12). However, it is unclear if very
acute changes (reduction) in respiration rate could also demonstrate positive improvements in
BP and sympathetic outflow.
Therefore, the purpose of this study was to determine whether a very acute (6 min) exposure
to CB could have a demonstrable impact on HR, BP, and MSNA. However, we first needed to
determine whether an individual’s SB rate (12-15 breaths/min) was similar to a CB rate of 12
breaths/min. Next, we sought to determine if the acute 6 min bout of CB would elicit a
reduction in HR, BP, and MSNA when compared to SB. It was hypothesized that there would
be a decrease in both cardiovascular variables and MSNA because CB would produce a slower
respiration rate than that observed during SB.
METHODS
Participants
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Twenty-one healthy subjects (10 women, 11 men) at least 18 years old gave written informed
consent to participate in the study, which was approved by the Institutional Review Board at
Northern Arizona University.
Table 1 illustrates the subject characteristics. Exclusionary criteria were: evidence of sleep
apnea, smoking or living with a smoker, obesity (body mass index of ≥ 30 kg/m2),
hypertension, currently taking or have taken in the last 6 months hormonal birth control or
hormonal replacement therapy, donated plasma or blood within the prior two months,
displayed any signs of cardiovascular, respiratory, renal diseases, or neurological disorders as
assessed through the medical history questionnaire.
Table 1. Subject characteristics.
Age (years)
Height (cm)
Weight (kg)
BMI (kg/m2)
Resting HR (beats/min)
Resting SBP (mmHg)
Resting DBP (mmHg)
Values are means±SD.

29±17
172±11
69±13
23±3
65±9
121±14
66±8

Protocol
Subjects reported to the lab for one visit. Prior to the study visit, subjects were asked to refrain
from exercise for ≥12 hours, to avoid consuming alcohol or caffeine for ≥48 hours, and to arrive
to the lab fasted for ≥8 hours. All studies were performed in the Cardiovascular Regulation
Lab at Northern Arizona University, which was maintained at a temperature of 21.6 ± 1.3 ˚C.
During instrumentation, subjects were at rest in the supine position on the patient table. A 3lead electrocardiogram (ECG module, Finapres Medical Systems, Amsterdam, The
Netherlands) was used for continuous monitoring of heart rate. Beat-by-beat BP (Finometer
MIDI, Finapres Medical Systems, Amsterdam, The Netherlands) was obtained from the
subject’s left middle or index finger while brachial artery pressure was obtained from the
subject’s right arm (SunTech Tango Plus, Morrisville, NC). Respiration was measured with a
piezoelectric respiratory belt transducer (ADInstruments, Colorado Springs, CO).
Microneurography was used to record MSNA from a recording electrode that was placed into
the peroneal nerve at the popliteal fossa. A subcutaneous reference electrode was placed 2-3
cm away from the recording electrode. Criteria for adequate MSNA recording included: 1)
pulse synchrony; 2) facilitation during the hypotensive phase of the Valsalva maneuver and
suppression during the hypertensive overshoot after release; 3) increases in response to breath
holding; and 4) insensitivity to a gentle skin touch or a loud shout (18).
Once instrumentation was complete and a clear MSNA signal was found, baseline data were
recorded. During SB, the subject was instructed to breathe at his/her normal pace. During CB,
the subject followed a computer program that prompted the subject when to inhale and exhale
(12 breaths/min). This respiration rate was chosen to avoid changes in heart rate variability, as
is seen during spontaneous breathing patterns, while the 6 minute trial time allowed for equal
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intervals in the breathing cycle (14). Subjects were given a 1 minute “pre-breathing” period to
familiarize themselves to each breathing protocol. Both trials lasted six minutes while HR, BP,
and MSNA were recorded continuously. There was a 5 min rest between SB and CB.
Statistical Analysis
Data were sampled and analyzed using LabChart (ADInstruments, Colorado Springs, CO).
All data were averaged for the 6 min data collection period. MSNA bursts were identified
from the integrated neurogram (2) and then were confirmed by trained personnel. Burst areas
of the integrated neurogram and BP were measured simultaneously on a beat-to-beat basis.
Burst frequency was defined as the number of bursts per min and burst incidence was used to
normalize burst frequency per 100 heart beats. Total activity was defined as the burst area of
the rectified and integrated neurogram. We assigned the largest burst amplitude during
baseline a value of 100 which represented our calibration burst (6, 16). Therefore, all other
bursts within a testing session were normalized against this value.
Data are reported as means ± SD. The 6 min averages of breathing frequency, HR, BP, and
MSNA variables (burst frequency, burst incidence, and total activity) were compared between
SB and CB using paired t-tests. All statistical analyses were performed in Sigma Plot using the
average of all 6 minutes of data collection. Significance was declared as P ˂ 0.05.
RESULTS
The subject characteristics are outlined in Table 1. Resting HR and BP values were obtained
during the screening process.
Figure 1 illustrates the breathing frequencies for
SB and CB. CB frequency was lower than SB (12 ±
1 vs 14 ± 4 breaths/min, P < 0.05).

MSNA burst frequency and burst incidence
(Figure 3) were lower during CB compared to SB
(burst frequency: 18±2 vs 14±10 bursts/min,
P<0.01; burst incidence: 28±19 vs 21±16 bursts/100
heart beats, P<0.01). There was no significant
difference in MSNA total activity between the two
trials (166±94 vs 145±102 a.u./min, P=0.145).
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HR, SBP, and DBP are illustrated in Figure 2. CB
induced a slight but significant increase in HR
(66±9 vs 67±9 beats/min for SB and CB,
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Figure 1. Individual breathing frequency for each
subject during SB and CB. Breathing frequency
was lower during CB compared to SB. *Difference
between SB and CB, P < 0.05.
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Figure 2. Cardiovascular responses during SB and CB.
HR was slightly but significantly elevated during CB
compared to SB. SBP and DBP were not different
between the two breathing trials. *Difference between
SB and CB, P<0.05.
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Figure 3. MSNA indices during SB and CB trials.
MSNA burst frequency and burst incidence were
lower during CB compared to SB. MSNA total
activity was not different between the two trials.
*Difference between SB and CB, P < 0.01.
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Table 2. Individual changes from SB to CB at minute 6 in HR, MSNA burst frequency, and MSNA burst
incidence.
Subject
∆HR (beats/min)
∆MSNA BF (bursts/min)
∆MSNA BI (bursts/100 heart
beats)

1
-13
9
14
2
4
5
5
3
2
-7
-10
4
3
8
12
5
-1
3
7
6
-1
4
6
7
-4
2
7
8
1
24
33
9
3
18
28
10
-3
-7
-10
11
-8
4
14
12
2
18
25
13
2
4
8
14
-5
0
0
15
-7
7
15
16
-2
3
8
17
1
-7
-10
18
-4
-4
-5
19
3
0
0
20
0
0
0
21
-3
4
7
HR, heart rate. MSNA BF, muscle sympathetic nerve activity burst frequency. MSNA BI, muscle sympathetic
burst incidence. SB, spontaneous breathing. CB, controlled breathing

DISCUSSION
The primary findings of this study were: 1) CB produced a lower breathing frequency than SB;
2) SBP and DBP were not different between the two trials; and 3) MSNA burst frequency and
incidence were lower during CB. These findings partially support our hypothesis in that CB
reduced MSNA indices but not BP.
Initially, we estimated that subjects would voluntarily choose a SB frequency around 12-15
breaths/min, consistent with the normal rates of respiration that are often reported in
physiology textbooks (10, 11). However, we observed a large range of SB rates, as low as 5
breaths/min to as high as 23 breaths/min. Only 38% of the subjects demonstrated a SB
frequency between 12 and 15 breaths/min.
When breathing rate was controlled (12 breaths/min) we observed no change in BP and a
reduction in MSNA burst frequency and incidence when compared with a SB frequency
condition. This is consistent with several studies that found BP responses have varied
depending on the length of the intervention. For example, Hering et al (2013) reported no
change in BP during a 15 min CB intervention, but a decrease in MSNA. Our study showed
similar findings (7).
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What is interesting about the current study, however, is that our subjects demonstrated a large
range in SB frequencies (5-23 breaths/min) but consistent MSNA reductions in response to CB.
Despite that some subjects increased their breathing frequency (24%), some decreased their
breathing frequency (71%), and others had no change (5%), we noted that 76% of subjects
showed a reduction in MSNA burst frequency and 81% in MSNA burst incidence when
comparing SB to CB. These data suggest that other factors, in addition to breathing frequency,
influence BP and MSNA. For example, MSNA was lower during CB in the four subjects who
had the lowest SB frequencies (i.e., 5-9 breaths/min.). Theoretically, as breathing frequency
increased in the CB condition, MSNA indices should have also increased.
It is likely that lung volume also plays a critical role in the BP and MSNA responses during
respiration. Others (4, 15) have reported that a low lung volume induces an increase in
MSNA. For example, Dempsey et al. (2002) reported that during low lung volume conditions,
respiratory motor output is at its lowest. Conversely, at higher lung volumes central
respiratory control is at its peak and is a strong inhibitor of MSNA (4). While we did not
directly measure tidal volume, we speculate that during the CB trial, subjects increased lung
(tidal) volume, which consequently inhibited sympathetic outflow. In subsequent studies, the
lung volume should be measured to confirm whether this is true.
Taken together, these findings might suggest that to gain the most benefit from meditative
breathing, or CB to reduce stress, there should be focus on both breathing frequency and
depth. We found that even an acute trial (6 min) of CB could elicit a reduction in sympathetic
outflow. We did not observe a concomitant decrease in BP but this may be due to the very
acute CB intervention. It is likely that in the long-term this may lower BP and could be
beneficial for those with hypertension (12). For example, some have reported decreases in BP
by as much as 9 mmHg after adopting a CB-type protocol (5, 7, 12). This provides evidence for
the benefits of non-pharmacologic interventions in the treatment of hypertension; however,
the full dose-response curve needs to be further characterized. In a normotensive population,
the effects of reduced MSNA indices may seem insignificant in the short term, but in the long
term the reduction of these parameters may reduce the risk for hypertension later in life. In
populations where the health of the cardiovascular system is in question, such as the
hypertensive population, a reduction in sympathetic outflow could influence their plan of
care.
One limitation of this study was that lung volume (tidal volume) was not measured.
Therefore, we cannot verify that during the CB trial the subjects increased their tidal volume.
We do not believe this changes the interpretation of our results, but further research should be
conducted considering this variable. Based on the work of St Croix et al (1999) and Dempsey
et al (2002) it is clear that a larger tidal volume inhibits MSNA.
In conclusion, a very acute CB intervention successfully lowers sympathetic outflow. The data
from this study suggest that this could be related to both altering the breathing frequency and,
likely, increasing the depth of breathing.
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